"Al-Jadai" Visits Guy's Hospital in London to Develop Advanced Therapies

Saudi Food and Drug Authority CEO Dr. Hisham Al-Jadai visited Guy's Hospital in London to review practices and experience in medical research and advanced therapies, and to explore opportunities to benefit from British expertise in developing the regulatory environment and supporting innovation in the healthcare sector.
During the visit, Al-Jadai learned about the experience of Guy's and St Thomas' NHS Foundation Trust, and the integrated model it offers combining specialized healthcare, scientific research and medical innovation, along with its activities in clinical research and the development of advanced therapies, particularly cell and gene therapies.
Discussed requirements for manufacturing advanced therapies, ensuring their quality, and standards for regulating clinical trials
The visit included a review of practices in manufacturing advanced therapies, quality assurance requirements, and standards regulating clinical trials, including "First-in-Human" trials and the regulatory aspects associated with them.
The visit also explored ways to benefit from the British experience in strengthening the integration of scientific research, manufacturing, and regulatory oversight, contributing to the development of the advanced therapies ecosystem and preparing an environment supportive of medical innovation.
The visit comes as part of the Saudi Food and Drug Authority's efforts to keep pace with scientific and technical developments and benefit from leading international experiences to develop the regulatory environment for advanced therapies and innovative medical products, in support of innovation in the healthcare sector and in line with the targets of the National Biotechnology Strategy and Saudi Vision 2030.